Vecoy Nanomedicines

Nano Traps for Destroying Viruses

Health Tech & Life Sciences
Non Active, Oct 2018 ceased to operate
Pre-Funding Pardesiya, Israel Founded 2010
LinkedIn
Last updated 2026-06-18
Total raised
$2.0M
Last: Grant 2013-11
Stage
Pre-Funding
Founded
2010
Headcount
1-10
HQ
Pardesiya, Israel
Sector
Health Tech & Life Sciences

About

Vecoy Nanomedicines administers novel nano-scale virus traps that capture and destroy viruses. The traps mimic human host cells to serve as virus decoys. Unlike existing antiviral treatments that target infected human cells, the patent-pending Vecoy technology targets the viruses before a cellular infection takes place. Furthermore, Vecoy has the potential to address the two major challenges of current medication: virus resistance to treatment and toxicity effects.

Funding history · 1 round · $2.0M total

Q&A

What is Vecoy Nanomedicines' primary business?
Vecoy Nanomedicines develops nano-scale virus traps that capture and destroy viruses by mimicking human host cells as decoys. Their technology targets viruses before cellular infection, aiming to address virus resistance and toxicity.
When was Vecoy Nanomedicines founded?
Vecoy Nanomedicines was founded in October 2010.
What is the current status of Vecoy Nanomedicines?
Vecoy Nanomedicines is currently inactive, having ceased operations in October 2018.
How much funding has Vecoy Nanomedicines raised in total?
Vecoy Nanomedicines has raised a total of $2,000,000.
When was Vecoy Nanomedicines' last funding round and what type was it?
Vecoy Nanomedicines' last funding round was a Grant in November 2013.
Which investors participated in Vecoy Nanomedicines' Grant round in November 2013?
The Grant round in November 2013 included participation from Naschitz and Brandes
What is the estimated employee count for Vecoy Nanomedicines?
Vecoy Nanomedicines has an estimated employee count in the 1-10 range.
Does Vecoy Nanomedicines hold any patents?
Yes, Vecoy Nanomedicines holds at least one patent.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

biopharmaceuticalviral-diseasesnanotechnologyinfectiondrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)